Pulmonary malignancy is one of the most frequent and fatal cancers in older patients. Studies have shown that lung cancer patients have a high incidence of lower respiratory tract infections. This is due to the fact that ...
Feb 6, 2024
0
0
For cancer patients, the harsh side effects of powerful drugs have long been the trade-off for living longer. Now, patients and doctors are questioning whether all that suffering is necessary.
Feb 6, 2024
0
1
In patients who undergo pulmonary resection for lung cancer, a major potential postoperative complication is venous thromboembolism (VTE)—a condition that develops when a blood clot forms in a vein—which can lead to part ...
Jan 29, 2024
0
0
Physicians at the University of Chicago Medicine are increasing their use of liquid biopsies, an emerging technology that detects signs of cancerous tumors with a simple blood test rather than an invasive needle procedure.
Jan 25, 2024
0
0
Northwestern Medicine investigators have identified a previously unknown regulator of tumor immune evasion, which may help improve the efficacy of current and future anti-tumor immunotherapies, according to recent findings ...
Jan 15, 2024
0
13
A new study led by Yale Cancer Center researchers at Yale School of Medicine has revealed a significant increase in patients starting immunotherapy within one month of death. Using a national clinical database, the researchers ...
Jan 4, 2024
0
12
Immune checkpoint inhibitors (ICIs) are used to treat a variety of different cancers. ICIs are antibodies that sensitize the body's own immune system to detect and destroy tumors. However, ICIs are not effective in all patients, ...
Jan 3, 2024
0
50
A study of more than 9,000 persons screened for lung cancer found that rates of downstream procedures and complications associated with screening are substantially higher in routine clinical practice than previously observed ...
Jan 1, 2024
0
0
A novel PET imaging tracer has been proven to safely and effectively detect a common cancer gene mutation that is an important molecular marker for tumor-targeted therapy. By identifying this mutation early, physicians can ...
Dec 20, 2023
0
2
An initiative at a Texas hospital contributed to reductions in chest tube duration, hospital length of stay and readmissions for patients with lung cancer who had a pulmonary lobectomy, according to new research published ...
Dec 1, 2023
0
0
